The human sperm proteome—Toward a panel for male fertility testing
Andrology · 2023-10 · 11 (7) · 1418-1436
DOI: 10.1111/andr.13431 ↗Kurz gefasst
Fachartikel in der Zeitschrift Andrology, online erschienen am 13.04.2023. Verfasst von Thomas Greither und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Reproductive Medicine and Andrology, Martin Luther University Halle-Wittenberg, Halle, Germany. Hauptthemen laut MEDLINE: Oligospermia, Infertility, Male. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Although male factor accounts for 40%–50% of unintended childlessness, we are far from fully understanding the detailed causes. Usually, affected men cannot even be provided with a molecular diagnosis.
Objectives
We aimed at a higher resolution of the human sperm proteome for better understanding of the molecular causes of male infertility. We were particularly interested in why reduced sperm count decreases fertility despite many normal‐looking spermatozoa and which proteins might be involved. Material and methods Applying mass spectrometry analysis, we qualitatively and quantitatively examined the proteomic profiles of spermatozoa from 76 men differing in fertility. Infertile men had abnormal semen parameters and were involuntarily childless. Fertile subjects exhibited normozoospermia and had fathered children without medical assistance.
Results
We discovered proteins from about 7000 coding genes in the human sperm proteome. These were mainly known for involvements in cellular motility, response to stimuli, adhesion, and reproduction. Numbers of sperm proteins showing at least threefold deviating abundances increased from oligozoospermia ( N = 153) and oligoasthenozoospermia ( N = 154) to oligoasthenoteratozoospermia ( N = 368). Deregulated sperm proteins primarily engaged in flagellar assembly and sperm motility, fertilization, and male gametogenesis. Most of these participated in a larger network of male infertility genes and proteins.
Discussion
We expose 31 sperm proteins displaying deviant abundances under infertility, which already were known before to have fertility relevance, including ACTL9, CCIN, CFAP47, CFAP65, CFAP251 (WDR66), DNAH1, and SPEM1. We propose 18 additional sperm proteins with at least eightfold differential abundance for further testing of their diagnostic potential, such as C2orf16, CYLC1, SPATA31E1, SPATA31D1, SPATA48, EFHB (CFAP21), and FAM161A.
Conclusion
Our results shed light on the molecular background of the dysfunctionality of the fewer spermatozoa produced in oligozoospermia and syndromes including it. The male infertility network presented may prove useful in further elucidating the molecular mechanism of male infertility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Reproductive Medicine and Andrology, Martin Luther University Halle-Wittenberg, Halle, Germany.
- Proteomics Core Facility, Institute of Molecular Biology, Mainz, Germany.
- Department of Quantitative Proteomics, Institute of Molecular Biology, Mainz, Germany.
- Anthropology, Institute of Organismic and Molecular Evolution, Johannes Gutenberg University Mainz, Mainz, Germany.
ORCID-Profile: Thomas Greither, Holger Herlyn
Zitieren
APA
Greither, T., Dejung, M., Behre, H. M., Butter, F., & Herlyn, H. (2023). The human sperm proteome—Toward a panel for male fertility testing. Andrology, 11(7), 1418-1436. https://doi.org/10.1111/andr.13431
Vancouver
Greither T, Dejung M, Behre HM, Butter F, Herlyn H. The human sperm proteome—Toward a panel for male fertility testing. Andrology. 2023;11(7):1418-1436. doi:10.1111/andr.13431
BibTeX
@article{Greither2023,
author = {Greither, Thomas and Dejung, Mario and Behre, Hermann M and Butter, Falk and Herlyn, Holger},
title = {The human sperm proteome—Toward a panel for male fertility testing},
journal = {Andrology},
year = {2023},
volume = {11},
number = {7},
pages = {1418--1436},
doi = {10.1111/andr.13431}
}
EUVIMED